Sci-fi
Fantasy Thriller
Publisher:
Page Publishing
Published:
February 2019
A
creature lying dormant beneath the Earth’s crust for over 35,000 years, waits
patiently to transform a dying young boy into one of mankind’s greatest leaders
in a time of dire need.
In
the year 2140 CE, Planet 9, more commonly known as Vixus, has resurfaced on the
edge of the Milky Way... the only known planet that periodically reverses its
rotation. Last seen in the middle of the Kuiper Belt in 2066 CE, it
mysteriously disappeared after being discovered by a Galactic Corps scout ship.
The unknown energy source enabling Vixus to spin in opposite directions
represented great power which could help turn the tide in a war Earth was
losing.
The
Fighting Fury, the Corps' finest platoon, has been called in to conduct a
search and rescue operation for several missing landing parties. Following a
fierce battle on the planet surface, Lieutenant Janet "Cat" Miles,
leader of this elite group of combat women, was captured. She soon found
herself imprisoned with the Corps' most fabled leader, Commander Jason Cody.
His name would forever be linked to the infamous wormhole hidden on Neptune's
dark side; an area of space now cautiously avoided by all due to the menace
which lurks within.
Paranoia
raced through both leaders' minds. Could he trust a woman who seemingly had no
imperfections? Could she trust a man who had vanished from sight years ago?
Earth's future laid in the balance as they struggled to overcome their mutual
distrust and acknowledge what those before them understood: "If you live
long enough, the wisdom will come."
About
the Author
Marc
Corwin is a retired entrepreneur and chief financial officer whose imagination
has been broadened by a childhood immersed in comic books. His first
publication has merited the following commentary: "The story's quick cuts
and ever-complicating plotline will keep readers entertained" - Kirkus
Reviews
Half
the royalties earned from the sale of "The Optical Lasso" will be
donated to the Grace Science Foundation to aid in the development of
cost-effective cures for the over 7000 known rare diseases currently afflicting
an estimated 350 million people worldwide.
Contact
Links
Purchase
Links
0 Σχόλια